Prognostic value of rubidium-82 positron emission tomography in patients after heart transplant

BA Mc Ardle, RA Davies, L Chen… - Circulation …, 2014 - Am Heart Assoc
Background—Cardiac allograft vasculopathy is a key prognostic determinant after heart
transplant. Detection and risk stratification of patients with cardiac allograft vasculopathy are …

PET assessment of epicardial intimal disease and microvascular dysfunction in cardiac allograft vasculopathy

S Chih, AY Chong, F Erthal, RA deKemp… - Journal of the American …, 2018 - jacc.org
Background: Cardiac allograft vasculopathy (CAV) is a leading cause of graft failure and
death after heart transplantation. Absolute myocardial blood flow (MBF) quantification using …

Reduced myocardial flow reserve by positron emission tomography predicts cardiovascular events after cardiac transplantation

MC Konerman, JJ Lazarus, RL Weinberg… - Circulation: Heart …, 2018 - Am Heart Assoc
Background: We evaluated the diagnostic and prognostic value of quantification of
myocardial flow reserve (MFR) with positron emission tomography (PET) in orthotopic heart …

Comparative prognostic and diagnostic value of myocardial blood flow and myocardial flow reserve after cardiac transplantation

RJH Miller, O Manabe, B Tamarappoo… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Cardiac allograft vasculopathy (CAV) is a major cause of graft failure after cardiac
transplantation. CAV is characterized by diffuse involvement of epicardial coronary arteries …

Serial assessment of coronary flow reserve by rubidium-82 positron emission tomography predicts mortality in heart transplant recipients

A Feher, A Srivastava, MA Quail, NE Boutagy… - Cardiovascular …, 2020 - jacc.org
Objectives This study aimed to evaluate the long-term prognostic value of serial assessment
of coronary flow reserve (CFR) by rubidium Rb 82 (82Rb) positron emission tomography …

Noninvasive physiologic assessment of cardiac allograft vasculopathy is prognostic for post-transplant events

KJ Clerkin, VK Topkara, MA Farr, R Jain… - Journal of the American …, 2022 - jacc.org
Background Cardiac allograft vasculopathy (CAV) causes impaired blood flow in both
epicardial coronary arteries and the microvasculature. A leading cause of post-transplant …

Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the …

GR Ciliberto, L Ruffini, M Mangiavacchi… - European heart …, 2001 - academic.oup.com
Aims To evaluate the accuracy of echocardiography in conjunction with quantitative high-
dose dipyridamole technetium-99m sestamibi tomography (SPECT) in detecting coronary …

Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy

PE Bravo, BA Bergmark, T Vita, VR Taqueti… - European heart …, 2018 - academic.oup.com
Aims Cardiac allograft vasculopathy (CAV) is a leading cause of death in orthotopic heart
transplant (OHT) survivors. Effective non-invasive screening methods are needed. Our aim …

PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients

YW Wu, YH Chen, SS Wang, HY Jui… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Cardiac allograft vasculopathy (CAV) is the major determinant of long-term survival after
heart transplantation. We aimed to evaluate the efficacy of PET as a noninvasive way to …

Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging

A Elhendy, RT van Domburg, P Vantrimpont… - The American journal of …, 2002 - Elsevier
Cardiac allograft vasculopathy is a major cause of mortality in heart transplant recipients.
The aim of this study was to assess the prognostic value of stress myocardial perfusion …